Nanomedicine for the prevention, treatment and imaging of atherosclerosis.

Nanomedicine for the prevention, treatment and imaging of atherosclerosis.

Veure altres versions (2)

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in developed countries, with an increasing prevalence due to an aging population. The pathology underpinning CVD is atherosclerosis, a chronic inflammatory state involving the arterial wall. Accumulation of low density lipo...

Descripció completa

Dades bibliogràfiques
Autors principals:	Psarros, C, Lee, R, Margaritis, M, Antoniades, C
Format:	Journal article
Idioma:	English
Publicat:	2012

Ítems similars

Nanomedicine for the prevention, treatment and imaging of atherosclerosis
per: Psarros, C, et al.
Publicat: (2012)

Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
per: Psarros, C, et al.
Publicat: (2012)

Nanomedicine for Diagnosis and Treatment of Atherosclerosis
per: Jingyun Cheng, et al.
Publicat: (2023-12-01)

Construction of dual nanomedicines for the imaging and alleviation of atherosclerosis
per: Shuihua Zhang, et al.
Publicat: (2020-01-01)

The role of adiponectin at different stages of atherosclerosis in heart failure: associations with myocardial redox state
per: Antonopoulos, A, et al.
Publicat: (2010)

Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis
per: Yongfang Lin, et al.
Publicat: (2024-06-01)

Nanoparticles: a promising therapeutic approach in atherosclerosis.
per: Antoniades, C, et al.
Publicat: (2010)

Biomimetic nanomedicines for precise atherosclerosis theranostics
per: Ying Tao, et al.
Publicat: (2023-11-01)

Editorial: Advances on targeted nanomedicines for atherosclerosis
per: Qinggong Han, et al.
Publicat: (2022-10-01)

Novel therapeutic strategies targeting vascular redox in human atherosclerosis.
per: Antonopoulos, A, et al.
Publicat: (2009)

Macrophage-targeted nanomedicine for the diagnosis and management of atherosclerosis
per: Ping Ping Hu, et al.
Publicat: (2022-09-01)

Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications
per: Xue Li, et al.
Publicat: (2022-10-01)

Statin treatment improves vascular redox state through a tetrahydrobiopterin-mediated re-coupling of endothelial nitric oxide synthase, in human atherosclerosis
per: Antoniades, C, et al.
Publicat: (2011)

Multifunctional phototheranostic nanomedicine for cancer imaging and treatment
per: D. Gao, et al.
Publicat: (2020-01-01)

Precision nanomedicine in atherosclerosis therapy: how far are we from reality?
per: Yee Shan Wong, et al.
Publicat: (2019-01-01)

Precision nanomedicine in atherosclerosis therapy: how far are we from reality?
per: Yee Shan Wong, et al.

Interrelationships between vascular superoxide and adiponectin biosynthesis in perivascular adipose tissue in human atherosclerosis
per: Bakogiannis, C, et al.
Publicat: (2010)

Shedding new light on atherosclerosis therapeutics: Nanomedicines targeting atherosclerotic immune microenvironment
per: Zhiyue Wang, et al.
Publicat: (2024-12-01)

Nanomedicine for renal cell carcinoma: imaging, treatment and beyond
per: Ruolin Wu, et al.
Publicat: (2023-01-01)

Adiponectin as a regulator of vascular redox state in human atherosclerosis
per: Margaritis, M
Publicat: (2016)

L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
per: Siasos, G, et al.
Publicat: (2007)

A NOVEL CROSS-TALK BETWEEN PERIVASCULAR ADIPOSE TISSUE AND THE ARTERIAL WALL CONTROLS REDOX STATE IN HUMAN ATHEROSCLEROSIS
per: Margaritis, M, et al.
Publicat: (2013)

A novel cross-talk between perivascular adipose tissue and the arterial wall controls redox state in human atherosclerosis
per: Margaritis, M, et al.
Publicat: (2013)

Insulin-induced vascular redox dysregulation in human atherosclerosis is ameliorated by dipeptidyl peptidase 4 inhibition
per: Akoumianakis, I, et al.
Publicat: (2020)

Macrophage-targeting Antisenescence nanomedicine enables in-Situ NO induction for Gaseous and antioxidative atherosclerosis intervention
per: Yuanyuan Peng, et al.
Publicat: (2025-06-01)

Insulin Treatment Induces Oxidative Stress in the Vascular Wall of Patients With Atherosclerosis Independently of Diabetes or Systemic Insulin Resistance: The Protective Role of DPP-IV Inhibition
per: Akoumianakis, I, et al.
Publicat: (2018)

Statins in coronary artery bypass grafting surgery: lipid lowering and beyond.
per: Margaritis, M, et al.
Publicat: (2012)

Macrophage membrane-functionalized manganese dioxide nanomedicine for synergistic treatment of atherosclerosis by mitigating inflammatory storms and promoting cholesterol efflux
per: Sijin Chen, et al.
Publicat: (2024-10-01)

Biomarkers of premature atherosclerosis.
per: Kampoli, A, et al.
Publicat: (2009)

An immunoregulator nanomedicine approach for the treatment of tuberculosis
per: Luona Yang, et al.
Publicat: (2023-05-01)

Atorvastatin rapidly reduces myocardial superoxide and peroxynitrite generation in human atherosclerosis, by suppressing NADPH-oxidase activity independently of LDL lowering
per: Antoniades, C, et al.
Publicat: (2011)

Challenges to Safe Nanomedicine Treatment
per: Chunhua Yang, et al.
Publicat: (2023-03-01)

Nanomedicine: Engineering of a tri-imageable nanoparticle for diagnostics
per: Bumb, A, et al.
Publicat: (2009)

The role of perivascular fat in the diagnosis and prognosis of atherosclerosis
per: Polkinghorne, M, et al.
Publicat: (2022)

Homocysteine lowering: any use in atherosclerosis?
per: Antoniades, C, et al.
Publicat: (2007)

Perivascular adipose tissue and coronary atherosclerosis
per: Mancio, J, et al.
Publicat: (2018)

State-of-the-art review article. Atherosclerosis affecting fat: What can we learn by imaging perivascular adipose tissue?
per: Antoniades, C, et al.
Publicat: (2019)

Nanomedicine Explored at Molecular Imaging Summit
per: Julie L. Sutcliffe PhD
Publicat: (2011-01-01)

The Role of Optical Imaging in Translational Nanomedicine
per: Evelien Hesemans, et al.
Publicat: (2022-08-01)

Advances in nanomedicines for lymphatic imaging and therapy
per: Pan He, et al.
Publicat: (2023-08-01)